Introduction {#S1}
============

Oral cancer is one of the most common human malignant tumors in the world ([@B28]; [@B24]). Despite progress in cancer treatment, for patients with oral cancer, the 5-year survival rate is still less than 50% ([@B8]). At present, the available treatments for oral cancer mainly include surgery, radiotherapy, and chemotherapy. After surgical treatment, it is easy to relapse, and the prognosis is poor. Although chemotherapy has effects to some extent, the tolerance and drug resistance of chemotherapy drugs are still severe problems faced by oral cancer patients. Therefore, it is necessary to find and develop a more effective and safer chemical molecular drug for treating the disease.

With the continuous development of nanomedicines, nanoparticles are now considered as a potential cancer treatment with bright future ([@B9]; [@B11]; [@B13]; [@B17]; [@B25]; [@B29]; [@B32]; [@B34]; [@B33]; [@B35]). The nanoparticle is small and can facilitate the various biological reactions ([@B3]; [@B5]). Tin oxide (SnO~2~) is an essential n-type wide bandgap (3.6 eV) semiconductor material. Currently, SnO~2~ nanoparticles are being used in different fields, including solar cells, gas sensors, catalysts, lithium-ion batteries, solid-state chemistry, etc. ([@B7]). Increasingly, SnO~2~ NP has more and more extensive use in the field of biomedicine, and studies have shown that SnO~2~ NP has antibacterial and antioxidant activity ([@B31]). For examples, in cell-related research, [@B30] observed that SnO~2~ NP can exert anti-human colorectal cancer and anti-lung cancer effects through cytotoxicity; [@B27] reported the cytotoxic response of SnO~2~ NP to hepatocellular carcinoma ([@B27]); [@B1] demonstrated that SnO~2~ NP could induce breast cancer cell toxicity through oxidative stress. In animal-related research, [@B36] found that SnO~2~ NP had an inhibitory effect on the weight gain of newborn rats. However, there is still little research on the mechanism of toxic effects of SnO~2~ NP at the cellular and molecular levels. Therefore, before SnO~2~ NP can be applied in the field of biomedicine, in-depth research on the possible biological roles of SnO~2~ is essential ([@B10]).

Since there is no relevant research on the role of SnO~2~ NP in the initialization and progression of oral cancer, two oral cancer cells CAL-27 and SCC-9 were selected in this study to explore the possibility of SnO~2~ NP in treating oral cancer by observing its effect on proliferation, invasion, apoptosis, and oxidative stress of the cells.

Materials and Methods {#S2}
=====================

Synthesis of SnO~2~ NP {#S2.SS1}
----------------------

SnO~2~ NP was synthesized by the sol-gel method, see reference for details ([@B2]). First, 5.0 g of SnCl~4~⋅5H~2~O was dissolved in 200.0 mL of ethanol (C~2~H~5~OH) and stirred for 30 min by a magnetic stirrer. Then, 6.0 mL of acetylacetone was added to hydrolyze SnO~2~, and the solution was refluxed through an 80°C condenser. After that, the solution was further dried for 3 h in a 90°C hot air oven (Thermo Fisher Scientific, United States) to obtain SnO~2~ gel, which was then calcined at 400-500°C for 2 h to obtain SnO~2~ NP.

Characterizations of SnO~2~ NP {#S2.SS2}
------------------------------

The absorption spectrum of SnO~2~ NP was measured using a spectrometer (UV-1800, Shimadzu, Japan) at a resolution of 0.5 nm and a wavelength range of 300--900 nm. The structure of SnO~2~ NP was analyzed by using Ku-Cα ray powder X-ray diffraction (XRD) with a wavelength of 1.54056 Å, and the XRD spectrum in the surrounding environment was recorded at a scan rate of 0.02°/s in the 2θ range of 20--80°. Besides, the characteristics of SnO~2~ NP were observed with a transmission electron microscope (TEM).

Cell Culture {#S2.SS3}
------------

Human oral cancer cell lines CAL-27 and SCC-9 were purchased from ATCC (United States). The cells were incubated in DMEM medium containing 10% fetal bovine serum (Gibco, United States), 100 U/mL penicillin, and 100 μg/mL streptomycin (Invitrogen, United States), with 5% carbon dioxide (CO~2~) at 37°C.

Experimental Grouping and Treatment of Cells Exposed to SnO~2~ NP {#S2.SS4}
-----------------------------------------------------------------

DMEM was used to prepare a SnO~2~ NP storage solution (1.0 mg/mL), which was then diluted to an appropriate concentration (5--200 μg/mL). Before the experiment, SnO~2~ NP of different concentrations was placed in the ultrasonic bath with 40 W for 15 min at room temperature, which could maintain nanoparticles being evenly distributed in DMEM and prevent aggregation. The cells were divided into the control group (DMEM group, 0 μg/mL) and experimental groups (SnO~2~ NP concentration was 5, 25, 50, 100, and 200 μg/mL), and two experimental treatment time points of 24 and 48 h were set.

Detection of Cell Proliferation Behaviors {#S2.SS5}
-----------------------------------------

Cell Counting Kit-8 (CCK-8, Donjindo, Japan) was used for the measurement. CAL-27 and SCC-9 cells were inoculated into 96-well plates at a density of 1 × 10^4^ cells/well. After 24 or 48 h of treatment for control and experimental groups, 10 μL of CCK-8 solution was added to each well for another 1 h of incubation at 37°C. After that, the absorbance at 450 nm (Absorbance, A) was measured with a multifunctional microplate reader (Bio-Rad, Untied States). A blank well (only containing medium and CCK-8 solution) was set in the experiment to counteract background interference. The formula for calculating cell proliferation activity is as follows ([@B6]; [@B18]):
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Each group has four replicates.

Cell Morphology Observation {#S2.SS6}
---------------------------

The morphological changes of cells in treatment groups were determined by a phase-contrast inverted microscope (Leica Microsystems Inc., United States).

Cell Scratch Test {#S2.SS7}
-----------------

First, cells were prepared for the control and experimental groups respectively, and then CAL-27 and SCC-9 cells were seeded on 6-well plates at a density of 2 × 10^5^ cell/well and cultured for 24 h. Straight lines parallel to the cell layer were then drawn using a sterile pipette tip. After that, the control and experimental groups were treated accordingly, and the cells were photographed at 0 and 24 h with the use of a phase-contrast inverted microscope. Finally, ImageJ was used to measure the width of the scratch area and calculate the cell migration rate. The formula is as follows: cell migration rate = (scratch width at 0 h−scratch width at 24 h) / scratch width at 0 h × 100%.

Cell Invasion Experiment {#S2.SS8}
------------------------

Transwell was used for the cell invasion test ([@B6]). First, cells were prepared for the control group and the experimental group. Then CAL-27 (6 × 10^4^ cell/well) and SCC-9 cells (8 × 10^4^ cell/well) inoculated into 200 μL of serum-free medium were plated in the upper chamber coated with Matrigel, and 500 μL of medium containing 10% fetal calf serum was added in the lower chamber. The cells were incubated at 37°C for 24 h, after which the cells on the membrane surface were fixed with 4% paraformaldehyde, stained with 0.1% crystal violet, and placed in a phase-contrast inverted microscope for cell counting.

Detection of Oxidative Stress Indicators {#S2.SS9}
----------------------------------------

The oxidative stress was evaluated by determining the levels of malondialdehyde (MDA) and reactive oxygen species (ROS). According to the instructions, the MDA detection kit for lipid peroxidation (S0131, Biyuntian, China) and the active oxygen detection kit (S0033, Biyuntian, China) were used for detection, respectively.

Western Blot to Detect Protein Expression {#S2.SS10}
-----------------------------------------

The cells after the experimental treatment were washed with pre-cooled PBS and lysed with a strong RIPA lysis buffer (Biyuntian, China) containing protease inhibitors, which was subsequently centrifuged at 16,000 *g* at 4°C for 20 min to retain the supernatant. Then, the protein quantification was measured by the BCA protein concentration detection kit (Biyuntian, China). After that, the protein was denatured by heating at 98°C for 10 min, and separated by SDS-PAGE gel electrophoresis. After electrophoresis, proteins on the gel were transferred to PVDF membrane (Millipore, United States), and the membrane was then blocked with a blocking solution (Biyuntian, China) for 1 h after the transfer. Subsequently, the membrane was incubated overnight at 4°C after the addition of the corresponding primary antibody. On the next day, the membrane was washed with TBST three times, and the secondary antibody conjugated with the corresponding horseradish peroxidase (HRP) was then incubated at room temperature for 2 h. After that, the membrane was washed three times with TBST, and the Western blot was developed with ECL color developing solution (Biyuntian, China). Finally, the grayscale analysis was performed with Photoshop CS6. The primary antibodies used in this experiment were cleaved Caspase-3 (ab2302 17 kDa), Caspase-3 (ab13847 17 kDa), cleaved Caspase-9 (ab2324 46 kDa), Caspase-9 (ab202068 46 kDa), matrix metalloproteinase 9 (Matrix metalloproteinase-9, MMP-9) (ab38898 92 kDa), MMP-2 (ab97779 74 kDa), G1/S-specific cyclin-D1 (Cyclin D1, CCND1) (ab134175 34 kDa), c-myc (Ab32072 57 kDa), Cytochrome C (ab133504 14 kDa), and β-actin (ab227387 42 kDa), of which β-actin serves as an internal reference protein.

Flow Cytometry to Detect Apoptosis {#S2.SS11}
----------------------------------

The flow cytometer Annexin V-FITC/PI double staining method was used for the detection. CAL-27 and SCC-9 cells were seeded on 6-well plates at a density of 2 × 10^5^ cells/well. After treatment for 24 or 48 h in the control and experimental groups, cells were digested with trypsin digestion solution without EDTA and centrifuged at 1,000 rpm for 5 min at room temperature to retain the cell pellet. Then, the cells washed with 1 mL of pre-chilled PBS were centrifuged at 3,000 rpm for 5 min at room temperature to retain the cell pellet, which was followed by PBS washing twice. After that, the cell pellet was added with 500 μL of binding buffer to resuspend, 10 μL PI and 5 μL Annexin V-FITC were added, and cultured in the dark. After incubation, the apoptosis was immediately analyzed using flow cytometry (BD Biosciences, United States).

Real-Time Fluorescence Quantitative PCR to Detect Expression Level of Target Genes {#S2.SS12}
----------------------------------------------------------------------------------

The cells after the experimental treatment were washed with pre-cooled PBS, and the total RNA was extracted from the cell line using TRIzol^®^ reagent (Invitrogen, United States). After that, the concentration and purity of the RNA were measured with a multifunctional microplate reader. According to the instructions of the reverse transcription kit (Takara, Japan), 1 μg of total RNA was used for PCR to obtain cDNA. Then, the SYBR Green kit (Takara, Japan) and target gene primers or internal reference gene (β-actin) primers were used to perform real-time fluorescence quantitative PCR (RT-qPCR). Finally, the expression cycle Ct value of each gene was measured, and the relative expression level was calculated according to this formula 2^--ΔΔ*Ct*^. Primer sequences are shown in [Table 1](#T1){ref-type="table"}.

###### 

Primer sequence.

  **Gene**       **Forward (5′→3′)**     **Reverse (5′→3′)**
  -------------- ----------------------- -----------------------
  MMP-9          CGCCAGTCCACCCTTGTG      CAGCTGCCTGTCGGTGAGA
  MMP-2          CGTCTGTCCCAGGATGACATC   ATGTCAGGAGAGGCCCCATA
  CCND1          GAACTACCTGGACCGCTTCC    TAGATGCACAGCTTCTCGGC
  C-myc          AGCAAACCTCCTCACAGCCC    ACTGTCCAACTTGACCCTCT
  Cytochrome C   CTTTGGGCGGAAGACAGGTC    TTATTGGCGGCTGTGTAAGAG
  β-actin        CATGTACGTTGCTATCCAGGC   CTCCTTAATGTCACGCACGAT

Statistical Analysis {#S3}
====================

All experiments were independently repeated three times. The measurement data obtained in the experiment are expressed as mean ± standard deviation, and software SPSS 18.0 was used for statistical analysis. Student's *t*-test was used for comparison between the two groups, and one-way ANOVA was used for comparison within the group when considering the single factors. *P* \< 0.05 was considered statistically significant.

Results {#S4}
=======

Physicochemical Characterization of SnO~2~ NP {#S4.SS1}
---------------------------------------------

As shown in [Figure 1A](#F1){ref-type="fig"}, the absorption spectrum of SnO~2~ NP ranges from 200 to 700 nm. The formula calculates the absorption coefficient (α) of SnO~2~ NP: α = A/d (A: absorbance, d: cuvette thickness) ([@B16]). According to the formula: (αhν) = A (*hν*−Eg) (where hν is the photon energy, A is a constant that does not depend on the photon energy), the absorption coefficient α was used to make Tauc plots ([@B15]). The analysis found that the energy band gap of SnO~2~ NP is 3.50 eV, which is consistent with other reports ([@B12]; [@B22]). It is also known that the energy band gap of semiconductor NP plays a critical role in the toxicity of tumor cells ([@B26]).

![Characterization of SnO~2~ NP. **(A)** Absorption spectra of SnO~2~ NP. Figure inset represents the bandgap energy of SnO~2~ NP. **(B)** XRD spectra of SnO~2~ NP. **(C,D)** TEM micrograph of SnO~2~ NP and a histogram of the size distribution of SnO~2~ NP.](fbioe-08-00768-g001){#F1}

X-ray diffraction analyzed the crystal structure of SnO2 NP. As shown in [Figure 1B](#F1){ref-type="fig"}, all peaks in XRD are related to the rutile structure of SnO~2~ (JCPDS No. 41-1445). According to the Scherrer equation: *d* = Kλ / βCos θ (where *K* = 0.9 is the shape factor, λ is the X-ray wavelength of Cu Kα rays (1.54 Å), θ is the Bragg diffraction angle, and β is the diffraction line at its maximum intensity (broadness) measured at half a radian), it is found that the average size of SnO~2~ NP is about 13 nm, and the XRD results are consistent with the results reported by other studies ([@B4]).

The appearance of SnO~2~ NP was detected by TEM and shown in [Figure 1C](#F1){ref-type="fig"}. The average TEM size of SnO~2~ NP was calculated based on more than 300 nanoparticles and found that the average TEM size was 27.45 ± 13.4 nm ([Figure 1D](#F1){ref-type="fig"}).

SnO~2~ NP Inhibit Proliferation of Oral Cancer Cells {#S4.SS2}
----------------------------------------------------

[Figure 2A](#F2){ref-type="fig"} showed that compared with the control group, SnO~2~ NP induced a significant decrease in the proliferation activity of CAL-27 cells in a concentration-dependent manner (50, 100, and 200 μg/mL) (all *P* \< 0.05), and the inhibition effect was more significant at 48 h than that at 24 h. When the concentration of SnO~2~ NP was lower than 50 μg/mL (5, 25 μg/mL), there was no significant effect on cell proliferation activity (all *P* \> 0.05). [Figure 2B](#F2){ref-type="fig"} showed that compared with the control group, SnO~2~ NP induced a significant decrease in the proliferation activity of SCC-9 cells in a concentration-dependent manner (25, 50, 100, and 200 μg/mL) (all *P* \< 0.05), and the treatment at 48 h has stronger effects on cell proliferation activity than that at 24 h. When the concentration of SnO~2~ NP was less than 5 μg/mL, there was no significant effect on cell proliferation activity (*P* \> 0.05). Since SnO~2~ can exert toxicity on oral cancer cells when the concentration greater than 50, 100 μg/mL was used as the treatment concentration in the SnO~2~ NP group.

![SnO~2~ NP inhibited cell viability in oral cancer cells. **(A,B)** The viability of CAL-27 and SCC-9 cells was measured after treatment of different concentrations of SnO~2~ NP at 24 or 48 h. *n* = 4, compared with control group, \**P* \< 0.05, \*\**P* \< 0.01, \*\*\**P* \< 0.001; compared with 24 h treated group, ^\#^*P* \< 0.05, ^\#\#^*P* \< 0.01; compared in groups, ^&⁣&⁣&^*P* \< 0.001.](fbioe-08-00768-g002){#F2}

SnO~2~ NP Changed Density Morphology of Oral Cancer Cells {#S4.SS3}
---------------------------------------------------------

[Figure 3A](#F3){ref-type="fig"} showed that compared with the control group, the treatment of 100 μg/mL SnO~2~ NP can significantly reduce the CAL-27 cell density, and the cell density was changed more significantly with the treatment of SnO~2~ NP at 48 h than that at 24 h. As shown in [Figure 3B](#F3){ref-type="fig"}, the changes caused by SnO~2~ NP on SCC-9 cells are consistent with the results from CAL-27 cells.

![SnO~2~ NP alters cell density and morphology in oral cancer cells (100×, 100 μm). **(A,B)** The changes in cell density and morphology in CAL-27 and SCC-9 cells.](fbioe-08-00768-g003){#F3}

SnO~2~ NP Inhibited Migration and Invasion of Oral Cancer Cells {#S4.SS4}
---------------------------------------------------------------

As shown in [Figures 4A,B](#F4){ref-type="fig"}, compared with the control group, SnO~2~ NP treatment significantly suppressed the migration of CAL-27 and SCC-9 cells (both *P* \< 0.05), and cells treated with SnO~2~ NP for 48 h has a weaker migration ability than those treated for 24 h (all *P* \< 0.05).

![SnO~2~ NP inhibited cell migration in oral cancer cells (50×, 200 μm). **(A,B)** The ability of cell migration was measured in CAL-27 and SCC-9 cells after treatment of 0 or 100 μg/mL SnO~2~ NP at 24 or 48 h. Compared with control group, \**P* \< 0.05, \*\**P* \< 0.01, \*\*\**P* \< 0.001; compared with 24 h treated group, ^\#^*P* \< 0.05, ^\#\#^*P* \< 0.01.](fbioe-08-00768-g004){#F4}

As shown in [Figures 5A,B](#F5){ref-type="fig"}, compared with the control group, SnO~2~ NP treatment significantly reduced the invasive ability of CAL-27 and SCC-9 cells (both *P* \< 0.05), and the effect on cell invasion was more significant with the treatment of SnO~2~ NP at 48 h than at 24 h (*P* \< 0.05).

![SnO~2~ NP inhibited cell invasion of oral cancer cells (100×, 100 μm). **(A,B)** The ability of cell invasion was measured in CAL-27 and SCC-9 cells after treatment of 0 or 100 μg/mL SnO~2~ NP at 24 or 48 h. Compared with control group, \**P* \< 0.05, \*\**P* \< 0.01, \*\*\**P* \< 0.001; compared with 24 h treated group, ^\#^*P* \< 0.05.](fbioe-08-00768-g005){#F5}

SnO2 NP Induced Apoptosis of Oral Cancer Cells {#S4.SS5}
----------------------------------------------

[Figure 6A](#F6){ref-type="fig"} indicated that compared with the control group, 100 μg/mL SnO~2~ NP can significantly induce apoptosis of CAL-27 cells (*P* \< 0.05), and the cells treated with SnO~2~ NP at 48 h have more significant change than that at 24 h. As shown in [Figure 6B](#F6){ref-type="fig"}, the apoptosis induced by SnO~2~ NP on SCC-9 cells was consistent with results with CAL-27 cells (*P* \< 0.05).

![SnO~2~ NP induced cell apoptosis in oral cancer cells. **(A,B)** Apoptosis was determined in CAL-27 and SCC-9 cells after treatment of 0 or 100 μg/mL SnO~2~ NP at 24 or 48 h. Compared with control group, \**P* \< 0.05, \*\**P* \< 0.01, \*\*\**P* \< 0.001; compared with 24 h treated group, ^\#^*P* \< 0.05.](fbioe-08-00768-g006){#F6}

SnO~2~ NP Induced Oxidative Stress in Oral Cancer Cells {#S4.SS6}
-------------------------------------------------------

As shown in [Figures 7A,C](#F7){ref-type="fig"}, CAL-27 cells treated with 100 μg/mL SnO~2~ NP, compared with those of the control group, significantly increased the levels of oxidative stress-related factors MDA and ROS (both *P* \< 0.05), and the cells treated with at 48 h changed more significant than at 24 h. As shown in [Figures 7B,D](#F7){ref-type="fig"}, the SnO~2~ NP-induced oxidative stress of SCC-9 cells was consistent with results from CAL-27 cells (*P* \< 0.05).

![SnO~2~ NP induced cell apoptosis in oral cancer cells. **(A,B)** MDA levels were determined in CAL-27 and SCC-9 cells after treatment of 0 or 100 μg/mL SnO~2~ NP at 24 or 48 h. **(C,D)** The effects of 0 or 100 μg/mL SnO~2~ NP on ROS concentrations were tested in CAL-27 and SCC-9 cells at 24 or 48 h. Compared with control group, \**P* \< 0.05, \*\**P* \< 0.01, \*\*\**P* \< 0.001; compared with 24 h treated group, ^\#^*P* \< 0.05, ^\#\#^*P* \< 0.05.](fbioe-08-00768-g007){#F7}

SnO~2~ NP Altered mRNA and Protein Expression of Oral Cancer Cell Proliferation, Migration, Invasion, Apoptosis, and Oxidative Stress-Related Genes {#S4.SS7}
---------------------------------------------------------------------------------------------------------------------------------------------------

CAL-27 cells are more sensitive to SnO~2~ NP stimulation in terms of migration, invasion, and apoptosis, and were selected in the study for the Western blot and RT-qPCR experiments.

As shown in [Figures 8A,B](#F8){ref-type="fig"}, compared with the control group, 100 μg/mL SnO~2~ NP treatment at both 24 and 48 h could not only significantly inhibit the expression of proliferation-related factors CCND1 and c-myc in CAL-27 cells to varying degrees, but also decrease the mRNA levels of migration and invasion related factors MMP-2 and MMP-9 (both *P* \< 0.05), to promote the mRNA expression of oxidative stress-related factors Cytochrome C (both *P* \< 0.05).

![SnO~2~ NP changed expression of proliferation, migration, invasion, apoptosis, and oxidative stress-related protein. **(A,B)** The changes of target mRNA levels in cells after treatment of 0 or 100 μg/mL SnO~2~ NP at 24 or 48 h. **(C,D)** The changes of target protein levels in cells after treatment of 0 or 100 μg/mL SnO~2~ NP at 24 or 48 h. Compared with a control group, \**P* \< 0.05, \*\**P* \< 0.01.](fbioe-08-00768-g008){#F8}

Moreover, as shown in [Figures 8C,D](#F8){ref-type="fig"}, compared with the control group, 100 μg/mL SnO~2~ NP treatment at 24 and 48 h can not only significantly inhibit the expression of proliferation-related factors CCND1, c-myc in CAL-27 cells, but also decrease the protein levels of migration and invasion related factors MMP-2 and MMP-9 (both *P* \< 0.05), promote the expression of such apoptosis-related proteins as cleaved Caspase-3, cleaved Caspase-9 and oxidative stress-related factor Cytochrome C (all *P* \< 0.05).

Discussion {#S5}
==========

SnO~2~ is a multifunctional metal oxide. Since SnO~2~ NP can be used as antibacterial agents, disinfectants, and other products with excellent performance, SnO~2~ NP has been gradually applied in the medical field. Recently, the critical role of SnO~2~ NP in cancer treatment has attracted widespread attention. Some studies have confirmed that SnO~2~ NP had a robust anti-cancer effect on specific cancer cells. For instance, SnO~2~ NP could induce human HCT116 and A549 cells to produce ROS *in vitro*, which leads to cell death ([@B30]); besides, it is found that SnO~2~ NP treatment can cause HepG2 cells to occur Morphological changes and cytotoxic effects ([@B27]); it is also demonstrated that SnO~2~ NP can induce oxidative stress in MCF-7 cells, prompting the cells to synthesize ROS, increasing H~2~O~2~ levels, triggering lipid peroxidation, reducing glutathione and antioxidant enzymes levels, and finally causing cell damage ([@B1]); Moreover, Lv found that SnO~2~ nanofibers can not only reduce the cell activity of hepatocellular carcinoma SMMC-7721 but also induce apoptosis. Western blot detection found that the expression of Caspase-3, the apoptosis-related protein, was increased ([@B21]).

In this study, SnO~2~ NP was prepared by the sol-gel method. Spectral analysis, XRD analysis, and TEM observation confirmed that the SnO~2~ NP that we produced were consistent with literature records and could be used for experiments. This study first found that SnO~2~ NP had anti-proliferative effects on two different kinds of oral cancer cells. Specifically, SnO~2~ NP induced a decrease in the activity of oral cancer cells in a dose-dependent manner, which became more evident with longer exposure time. This result is consistent with previous studies on the effects of SnO~2~ NP on other cancers ([@B27]; [@B30]). At the same time, the protein and mRNA expressions of CCND1 and c-myc, the cell proliferation-related genes, were also detected. Some studies have found that CCND1 can regulate the cell cycle by controlling the G1/S phase transition, and increased expression of CCND1 will lead to the occurrence of cancer ([@B23]). As a carcinogenic transcription factor, C-Myc recognizes E-box and its related sequences in the target gene promoter. The increase of C-Myc level significantly improves the tumor proliferation ability ([@B20]). The study indicated that SnO~2~ NP could inhibit the expression of CCND1 and c-myc in oral cancer cells, thereby exerting an inhibitory effect on cell proliferation. Also, the morphological changes in oral cancer cells after being treated with SnO~2~ NP were observed and found that the cells shrank significantly. The cell density decreased, which further demonstrated that SnO~2~ NP could exert cytotoxicity on oral cancer cells.

It is known that the cytotoxicity induced by SnO~2~ NP is involved in the generation of oxidative stress, and [@B1] demonstrated that in breast cancer cells SnO~2~ NP induced a dose-dependent increase in the production of oxidative products. As we all know, the production and removal of ROS in a normal healthy body are in a dynamic balance. When harmful factors destroy this balance, the level of free radical scavenging enzymes in the body will increase the production of ROS. Besides, it may also trigger the cleavage of lipid peroxides to MDA, which plays a cytotoxic role ([@B14]). Therefore, MDA and ROS are effective markers of the occurrence of oxidative stress in the body. This study found that SnO2 NPs increased MDA and ROS levels in CAL-27 and SCC-9 cells, and by detecting the expression of oxidative stress-related factors Cytochrome C, it was found that SnO2 NPs can induce oral cancer cells to produce an increased amount of Cytochrome C, thereby increasing oxidative stress. The above results indicated that SnO~2~ NP could cause cell damage by inducing oxidative stress.

Cytochrome c plays a vital role in apoptosis in addition to its role in oxidative stress. It is known that caspase-3 and caspase-9 belong to the cysteine aspartic protease family and act as intermediary proteins in the degradation of proteolytic enzymes during apoptosis. In mammals, cytochrome c together with apoptosis-activating factor 1 activates caspase 9, which subsequently leads to caspase-3 activation, finally triggering a cascading waterfall effect and inducing apoptosis. This study found that SnO2 NPs can significantly increase the number of apoptosis of oral cancer cells, and the expression levels of apoptosis-related proteins Cleared Caspase-3 and Cleared Caspase-3 were also increased at different levels. These results suggest that SnO~2~ NP can cause cell damage by inducing apoptosis.

In addition to apoptosis and oxidative stress, the effects of SnO~2~ NP treatment on migration and invasion of oral cancer cells were also examined in this study. The results showed that oral cancer cells exposed to SnO~2~ NP can significantly reduce their migration and invasion ability, and this inhibitory effect became more apparent, with the prolonged exposure time. In addition to visually observing changes in cell function, the mRNA and protein expression of migration and invasion related genes MMP-2 and MMP-9 were also detected. MMPs are known to be essential for tumor angiogenesis and metastasis, and the destruction of the basement membrane by activating MMPs is a crucial step for cancer invasion and metastasis ([@B19]). Therefore, inhibition of MMPs expression can provide an initial target for preventing tumor metastasis. This study found that after treatment with SnO~2~ NP, both MMP-2 and MMP-9 protein and mRNA expressions in oral cancer cells were down-regulated by varying degrees. This result is consistent with the results of migration and invasion experiments, suggesting that SnO~2~ NP can inhibit the migration and invasion of oral cancer cells.

Despite the results shown in this study, because anti-tumor polymer nano-drugs are a new research hotspot and the research history is still relatively short, there are still a series of problems in this research, such as the lack of in-depth understanding of metabolic kinetics and biodistribution of the nano-drugs. For targeted tumor therapy, key factors (such as particle size, charge, surface chemistry) are still lacking in-depth exploration. Furthermore, due to the complexity of tumors, the therapeutic effect of nanomedicine in different tumor types and tumors with different stages of progressions may be different. Nevertheless, nanotechnology is still a very important hot subject that affects medicine. Although the research and development of nanotechnology-applied medicine are still only in its early stages, due to its rapid development, it will surely develop into a new discipline and new industry.

Conclusion {#S6}
==========

In summary, we found in this study that SnO~2~ NP can exert cytotoxic effects on oral cancer cells by inhibiting cell proliferation, migration, and invasion abilities, and can also induce oxidative stress and apoptosis. Therefore, it is indicated that SnO~2~ NP may have anti-oral cancer effects, which can provide a basis for future research and clinical application and has important theoretical value. However, more in-depth animal experiments and clinical trials are still needed to confirm its clinical value. This is a major limitation of this study and a direction for future research.
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